If you want to address civilization and society's issues, then you have to do it with the city," Urban Partners' co-CEO Claus ...

The analysis provides a standardized way to compare existing holdings against new ideas ... and the firm has introduced a structure that has allowed most of the team to buy an equity stake ...

Those themes allow the managers a lot of leeway, and the portfolio contains many familiar names common in other global large-cap portfolios such as Nvidia, Microsoft, and Novo Nordisk. They look ...

Novo Holdings’ investment alongside Biocomposites’ existing shareholder, TA Associates, will help the company scale its ...

Novo Banco SA, a Portuguese lender that’s majority-owned by Lone Star, said its planned initial public offering could take ...

Eli Lilly has called on financial regulators to look into the antitrust implications of Novo Holdings' purchase of Catalent and the sale of three manufacturing facilities to Novo Nordisk.

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.

Novo Nordisk stock has fallen roughly 40% from a peak it reached last June. The U.S. Food and Drug Administration recently confirmed Novo Nordisk is producing enough Ozempic and Wegovy to meet ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Novo Nordisk (NVO – Research Report) and Veeva Systems (VEEV ...

For the final quarter of 2024, the fund gained 1.08%, trailing the 2.41% advance of the benchmark S&P 500® index. Read more ...

Consumers are on board, with an estimated 26% of U.S. adults planning to take a weight loss drug in 2025, according to ...

Annual results for the year ended 31 December 2024 2024 was a landmark year for the Company, which was promoted to the FTSE 100 after the combination with Witan Investment Trust Plc ('Witan'). The ...